Related references
Note: Only part of the references are listed.Characterization and Expression of Sphingosine 1-Phosphate Receptors in Human and Rat Heart
Naseer Ahmed et al.
FRONTIERS IN PHARMACOLOGY (2017)
Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2017)
Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion
Carlos G. Santos-Gallego et al.
CIRCULATION (2016)
Effects of Quercetin in a Rat Model of Hemorrhagic Traumatic Shock and Reperfusion
Virginia Chamorro et al.
MOLECULES (2016)
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease
Nurgul Aytan et al.
SCIENTIFIC REPORTS (2016)
Sphingosine-1-Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca2+ Sensitivity and Na+/H+ Exchange and Mediates Protection by Ischemic Preconditioning
Petra Keul et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke
Wentao Li et al.
FRONTIERS IN NEUROLOGY (2016)
Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury
Matthew L. Stone et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke A Pilot Trial
Zilong Zhu et al.
CIRCULATION (2015)
Molecular Basis of Cardioprotection Signal Transduction in Ischemic Pre-, Post-, and Remote Conditioning
Gerd Heusch
CIRCULATION RESEARCH (2015)
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study
Rocco Totaro et al.
MULTIPLE SCLEROSIS INTERNATIONAL (2015)
Fingolimod May Support Neuroprotection via Blockade of Astrocyte Nitric Oxide
Emanuela Colombo et al.
ANNALS OF NEUROLOGY (2014)
Inflammatory triggers of acute rejection of organ allografts
Daniel N. Mori et al.
IMMUNOLOGICAL REVIEWS (2014)
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study
Niklas Bergvall et al.
PLOS ONE (2014)
Processing of the Explanted Heart
Jiangping Song et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2014)
Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation
P. Markowski et al.
BASIC RESEARCH IN CARDIOLOGY (2013)
Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats
Hong Li et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Epidemiology of Heart Failure
Veronique L. Roger
CIRCULATION RESEARCH (2013)
Systematic Review and Meta-Analysis of the Efficacy of Sphingosine-1-Phosphate (S1P) Receptor Agonist FTY720 (Fingolimod) in Animal Models of Stroke
Junfeng Liu et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2013)
Oxidative stress and myocardial injury in the diabetic heart
David M. Ansley et al.
JOURNAL OF PATHOLOGY (2013)
Cardioprotection: chances and challenges of its translation to the clinic
Gerd Heusch
LANCET (2013)
Cardiac Per2 Functions as Novel Link between Fatty Acid Metabolism and Myocardial Inflammation during Ischemia and Reperfusion Injury of the Heart
Stephanie Bonney et al.
PLOS ONE (2013)
Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice
Young-Bin Oh et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Interplay Between SAFE and RISK Pathways in Sphingosine-1-Phosphate-Induced Cardioprotection
Sarin J. Somers et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
Ischemia-Reperfusion Injury in Stroke
May Nour et al.
INTERVENTIONAL NEUROLOGY (2012)
Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis
Kenji Chiba et al.
PHARMACEUTICALS (2012)
Mitochondrial STAT3 Activation and Cardioprotection by Ischemic Postconditioning in Pigs With Regional Myocardial Ischemia/Reperfusion
Gerd Heusch et al.
CIRCULATION RESEARCH (2011)
The Origin of Fibroblasts and Mechanism of Cardiac Fibrosis
Guido Krenning et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature
Jerold Chun et al.
PHARMACOLOGICAL REVIEWS (2010)
Pig Embryonic Pancreatic Tissue as a Source for Transplantation in Diabetes Transient Treatment With Anti-LFA1, Anti-CD48, and FTY720 Enables Long-Term Graft Maintenance in Mice With Only Mild Ongoing Immunosuppression
Dalit Tchorsh-Yutsis et al.
DIABETES (2009)
Toward a new cold and warm nondepolarizing, normokalemic arrest paradigm for orthotopic heart transplantation
Donna M. Rudd et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Analysis of apoptosis by cytometry using TUNEL assay
Zbigniew Darzynkiewicz et al.
METHODS (2008)
Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia
Jianqing Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Angiotensin-(1-7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo:: role of the AT1 and Mas receptors
Jorge F. Giani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion injury
Jakob Vinten-Johansen et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation
Helio Tedesco-Silva et al.
TRANSPLANTATION (2006)
C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling
M Khan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Controversies in Cardiology 4 - Controversies in ventricular remodelling
LH Opie et al.
LANCET (2006)
A look between the cardiomyocytes: The extracellular matrix in heart failure
EC Miner et al.
MAYO CLINIC PROCEEDINGS (2006)
Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion
M Tanaka et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Oxidative stress during myocardial ischaemia and heart failure
R Ferrari et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Superoxide dismutase mimetic M40401 reduces ischemia-reperfusion injury and graft coronary artery disease in rodent cardiac allografts
S Murata et al.
TRANSPLANTATION (2004)
Lysophospholipid receptors: Signaling and biology
I Ishii et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration
DM Anselmo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
Identification of a novel role for sphingolipid signaling in TNFα and ischemic preconditioning mediated cardioprotection
S Lecour et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Cardiac transplantation: the final therapeutic option for the treatment of heart failure
MM Koerner et al.
CURRENT OPINION IN CARDIOLOGY (2000)
Share Paper
